Are entrepreneurial venture's innovation rates sensitive to investor complementary assets? Comparing biotech ventures backed by corporate and independent VCs

Strategic Management Journal

Volumn 37, Issue 5, 2016, Pages 819-834

  Alvarez Garrido, Elisa ^a   Dushnitsky, Gary ^b  

^a GEORGIA STATE UNIVERSITY   (United States)

^b LONDON BUSINESS SCHOOL   (United Kingdom)

Author keywords

corporate venture capital; entrepreneurial ventures; innovation; patents; publications; venture capital

Indexed keywords

BIOTECHNOLOGY; INNOVATION; INVESTMENTS;

CORPORATE VENTURE CAPITAL; ENTREPRENEURIAL VENTURES; PATENTS; PUBLICATIONS; VENTURE CAPITAL;

PATENTS AND INVENTIONS;

EID: 84922813086     PISSN: 01432095     EISSN: 10970266     Source Type: Journal    
DOI: 10.1002/smj.2359     Document Type: Article

References (76)

1. Acs ZJ, Audretsch DB,. 1988. Innovation in large and small firms: an empirical analysis. American Economic Review 78 (4): 678-690.
2. Acs ZJ, Morck R, Shaver JM, Yeung B,. 1997. The internationalization of small and medium-sized enterprises: a policy perspective. Small Business Economics 9 (1): 7-20.
3. Aggarwal VA, Hsu DH,. 2009. Modes of cooperative R&D commercialization by start-ups. Strategic Management Journal 30 (8): 835-864.
4. Agrawal A, Cockburn I, McHale J,. 2006. Gone but not forgotten: knowledge flows, labor mobility, and enduring social relationships. Journal of Economic Geography 6 (5): 571-591.
5. Agrawal A, Henderson R,. 2002. Putting patents in context: exploring knowledge transfer from MIT. Management Science 48 (1): 44-60.
6. Ahuja G, Katila R,. 2001. Technological acquisitions and the innovation performance of acquiring firms: a longitudinal study. Strategic Management Journal 22 (3): 197-220.
7. Azoulay P, Ding W, Stuart T,. 2009. The impact of academic patenting on the rate, quality and direction of (public) research output. Journal of Industrial Economics 57 (4): 637-676.
8. Benson D, Ziedonis RH,. 2009. Corporate venture capital as a window on new technologies: implications for the performance of corporate investors when acquiring startups. Organization Science 20 (2): 329-351.
9. Berger AN, Miller NH, Petersen MA, Rajan RG, Stein JC,. 2005. Does function follow organizational form? Evidence from the lending practices of large and small banks. Journal of Financial Economics 76 (2): 237-269.
10. Bottazzi L, Da Rin M, Hellmann T,. 2008. Who are the active investors? Evidence from venture capital. Journal of Financial Economics 89: 488-512.
11. Cameron AC, Trivedi PK,. 2009. Microeconometrics using Stata. Stata Press: College Station, TX.
12. Catalini C., 2013. Microgeography and the direction of inventive activity.
13. Cockburn I, Henderson R,. 1998. Absorptive capacity, coauthoring behavior, and the organization of research in drug discovery. Journal of Industrial Economics 46 (2): 157-182.
14. Cockburn I, Henderson R, Stern S,. 1999. Balancing incentives: the tension between basic and applied research. Boston University and NBER Working Paper No. 6882: Boston, MA.
15. Cox E, Katila R, Eisenhardt KM,. 2013. Who Takes you to the Dance? How Funding Partners Influence Innovative Activity in Young Firms. University of Washington: Seattle.
16. Czerepak EA, Ryser S,. 2008. Drug approvals and failures: implications for alliances. Nature Reviews Drug Discovery 7: 197-198.
17. Dushnitsky G,. 2012. Corporate venture capital in the 21st century: an integral part of firms' innovation toolkit. In The Oxford Handbook of Venture Capital, Cumming D, (ed). Oxford University Press: Oxford, UK.
18. Dushnitsky G, Lenox MJ,. 2005a. When do firms undertake R&D by investing in new ventures? Strategic Management Journal 26 (10): 947-965.
19. Dushnitsky G, Lenox MJ,. 2005b. When do incumbents learn from entrepreneurial ventures? Corporate venture capital and investing firm innovation rates. Research Policy 34: 615-639.
20. Dushnitsky G, Shapira Z,. 2010. Entrepreneurial finance meets organizational reality: comparing investment practices and performance of corporate and independent venture capitalists. Strategic Management Journal 31: 990-1017.
21. Dushnitsky G, Shaver JM,. 2009. Limitations to inter-organizational knowledge acquisition: the paradox of corporate venture capital. Strategic Management Journal 30 (10): 1045-1064.
22. Fitza M, Matusik SF, Mosakowski E,. 2009. Do VCs matter? The importance of owners on performance variance in start-up firms. Strategic Management Journal 30: 387-404.
23. Fleming L, King C, Juda AI,. 2007. Small worlds and regional innovation. Organization Science 18 (2): 938-954.
24. Furman JL, Murray F, Stern S,. 2010. More for the research dollar. Nature 468: 757-758.
25. Gans JS, Stern S,. 2003. The product market and the market for "ideas": commercialization strategies for technology entrepreneurs. Research Policy 32: 333-350.
26. Giovannetti GT, Morrison SW,. 2000. Convergence: The Biotechnology Industry Report. Ernst & Young: Palo Alto, CA.
27. Gittelman M, Kogut B,. 2003. Does good science lead to valuable knowledge? Biotechnology firms and the evolutionary logic of citation patterns. Management Science 49 (4): 366-382.
28. Goldfarb B,. 2008. The effect of government contracting on academic research: does the source of funding affect scientific output? Research Policy 37 (1): 41-58.
29. Gompers PA,. 1995. Optimal investment, monitoring, and the staging of venture capital. Journal of Finance 50 (5): 1461-1489.
30. Gompers PA, Lerner J,. 2000. The determinants of corporate venture capital success: organizational structure, incentives, and complementarities. In Concentrated Corporate Ownership, Morck RK, (ed). University of Chicago Press: Chicago, IL.
31. Gompers PA, Lerner J,. 2004. The Venture Capital Cycle (2nd edn). MIT Press: Cambridge, MA.
32. Gorman M, Sahlman WA,. 1989. What do venture capitalists do? Journal of Business Venturing 4: 231-248.
33. Griliches Z,. 1990. Patent statistics as economic indicators: a survey. Journal of Economic Literature 28 (4): 1661-1707.
34. Griliches Z,. 1994. Productivity, R&D, and the data constraint. American Economic Review 84 (1): 1-23.
35. Guler I,. 2007. Throwing good money after bad? Political and institutional influences on sequential decision making in the venture capital industry. Administrative Science Quarterly 52 (2): 248-285.
36. Guler I, Guillén MF,. 2010. Home country networks and foreign expansion: evidence from the venture capital industry. Academy of Management Journal 53 (2): 390-410.
37. Heeley MB, Matusik SF, Jain N,. 2007. Innovation, appropriability, and the underpricing of initial public offerings. Academy of Management Journal 50 (1): 209-225.
38. Henricks M., 2002. Answering the call. Entrepreneur 30 (7): 19-21.
39. Hill CW, Jones GR,. 2007. Strategic Management Theory: An Integrated Approach (7th edn). Houghton Mifflin: Boston, MA.
40. Hsu DH,. 2006. Venture capitalists and cooperative start-up commercialization strategy. Management Science 52 (2): 204-219.
41. Hsu DH,. 2007. Experienced entrepreneurial founders, organizational capital, and venture capital funding. Research Policy 36: 722-741.
42. Hsu DH, Ziedonis R,. 2013. Resources as dual sources of advantage: implications for valuing entrepreneurial-firm patents. Strategic Management Journal 34 (7): 761-781.
43. Huang KG, Murray F,. 2009. Does patent strategy shape the long-run supply of public knowledge? Evidence from human genetics. Academy of Management Journal 52 (6): 1193-1221.
44. Hughes SS,. 2001. Making dollars out of DNA: the first major patent in biotechnology and the commercialization of molecular biology, 1974-1980. Isis 92 (3): 541-575.
45. Jaffe AB, Trajtenberg M, Henderson R,. 1993. Geographic localization of knowledge spillovers as evidenced by patent citations. Quarterly Journal of Economics 108 (3): 577-598.
46. Kaplan SN, Schoar A,. 2005. Private equity performance: returns, persistence and capital flows. Journal of Finance 60 (4): 1791-1823.
47. Keil T, Autio E, George G,. 2008. Corporate venture capital, disembodied experimentation and capability development. Journal of Management Studies 45 (8): 1475-1505.
48. Kortum S, Lerner J,. 2000. Assessing the contribution of venture capital to innovation. RAND Journal of Economics 31 (4): 674-692.
49. Lerner J,. 1994. Venture capitalists and the decision to go public. Journal of Financial Economics 43: 133-156.
50. Levin RC, Klevorick AK, Nelson RR, Winter SG,. 1987. Appropriating the returns from industrial research and development. Brookings Papers on Economic Activity 1987 (3): 783-831.
51. Lim K,. 2004. The relationship between research and innovation in the semiconductor and pharmaceutical industries (1981-1997). Research Policy 33 (2): 287-321.
52. Maula MVJ,. 2007. Corporate venture capital as a strategic tool for corporations. In Handbook of Research on Venture Capital, Landström H, (ed). Edward Elgar Publishing, Ltd.: Cheltenham, UK.
53. Mullahy J,. 1997. Instrumental-variable estimation of count data models: applications to models of cigarette smoking behavior. Review of Economics and Statistics 79 (4): 586-593.
54. Murray F, Stern S,. 2007. Do formal intellectual property rights hinder the free flow of scientific knowledge? An empirical test of the anti-commons hypothesis. Journal of Economic Behavior and Organization 63 (4): 648-687.
55. Northrup JP, Tarasova M, Kalowski L,. 2012. The pharmaceutical sector: rebooted and reinvigorated. In The Business of Healthcare Innovation, Burns LR, (ed). Cambridge University Press: Cambridge, MA.
56. NVCA, 2011. " Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform." Accessible online: http://www.nvca.org/vital-signs-data-slides.pdf.
57. Osherovich L,. 2011. Hedging against academic risk. SciBX 4 (15); doi: 10.1038/scibx.2011.416, Published online April 14, 2011. Available at http://www.nature.com.ezproxy.gsu.edu/scibx/journal/v4/n15/full/scibx.2011.416.html
58. Pisano G,. 2006. Science Business: The Promise, the Reality, and the Future of Biotech. Harvard Business School Press: Boston, MA.
59. Rosenberg N,. 1990. Why do firms do basic research (with their own money)? Research Policy 19 (2): 165-174.
60. Rothaermel FT, Thursby M,. 2007. The nanotech versus the biotech revolution: sources of productivity in incumbent firm research. Research Policy 36: 832-849.
61. Samila S, Sorenson O,. 2010. Venture capital as a catalyst to commercialization. Research Policy 39 (10): 1348-1360.
62. Samila S, Sorenson O,. 2011. Venture capital, entrepreneurship, and economic growth. Review of Economics and Statistics 93 (1): 338-349.
63. Sapienza HJ,. 1992. When do venture capitalists add value? Journal of Business Venturing 7: 9-27.
64. Sauermann H, Stephan P,. 2013. Conflicting logics? A multidimensional view of industrial and academic science. Organization Science 24 (3): 889-909.
65. Scotchmer S,. 2004. Innovation and Incentives. MIT Press: Cambridge, MA.
66. Sorenson O, Stuart T,. 2001. Syndication networks and the spatial distribution of venture capital investments. American Journal of Sociology 106 (6): 1546-1588.
67. Stern S,. 2004. Do scientists pay to be scientists? Management Science 50 (6): 835-853.
68. Stokes DE,. 1997. Pasteur's Quadrant: Basic Science and Technological Innovation. Brookings Institution Press: Washington, DC.
69. Stuart T, Hoang H, Hybels RC,. 1999. Interorganizational endorsements and the performance of entrepreneurial ventures. Administrative Science Quarterly 44 (2): 315-349.
70. Terza JV,. 1998. Estimating count data models with endogenous switching: sample selection and endogenous treatment effects. Journal of Econometrics 84 (1): 129-154.
71. Terza JV, Basu A, Rathouz PJ,. 2008. Two-stage residual inclusion estimation: addressing endogeneity in health econometric modeling. Journal of Health Economics 27 (3): 531-543.
72. Wadhwa A, Kotha S,. 2006. Knowledge creation through external venturing: evidence from the telecommunications equipment manufacturing industry. Academy of Management Journal 49 (4): 819-835.
73. Wooldridge JM,. 1997. Quasi-likelihood methods for count data. In Handbook of Applied Econometrics, Vol. 2: Microeconometrics, Pesaran MH, Schmidt P, (eds). Blackwell: Oxford, UK.
74. Wooldridge JM,. 2002. Econometric Analysis of Cross Section and Panel Data. MIT Press: Cambridge, MA.
75. Zucker LG, Darby MR, Armstrong J,. 2002. Commercializing knowledge: university science, knowledge capture, and firm performance in biotechnology. Management Science 48 (1): 138-153.
76. Zucker LG, Darby MR, Brewer MB,. 1998. Intellectual human capital and the birth of U.S. biotechnology enterprises. American Economic Review 88 (4): 290-306.